- $16.13m
- $9.90m
- $28.51m
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt
Brief: Bionano Genomics Q1 Revenue USD 6.7 Million
Brief: Bionano Genomics may offer and sell up to $400 mln of securities - SEC Filing
Bionano Genomics Q4 revenue falls as instrument sales decline
Genome mapping firm Bionano Q3 rev beats estimates on higher utilization by routine users
Brief: Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
Brief: Bionano Genomics Announces Pricing Of $10 Million Public Offering
Bionano Genomics Inc reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Inc expected to post a loss of $2.41 a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of $2.41 a share - Earnings Preview
Bionano Genomics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Bionano Genomics Q1 Revenue USD 6.5 Million
Bionano Genomics Inc expected to post a loss of $3.02 a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of $3.02 a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Beacon Roofing Supply, Carvana, Reinsurance Group of America
Bionano Genomics Inc reports results for the quarter ended December 31 - Earnings Summary